Construction of stable packaging cell lines for clinical lentiviral vector production

Cited by (108)

Items 101–108 of 108

1. SLC20A1 knockout to stably express a fusogenic gibbon ape leukemia virus envelope glycoprotein for lentiviral vector production
   Rodrigo José Nogueira, Ana Filipa Rodrigues, Daniel Alexandre Mestre, Ana Sofia Coroadinha · 2025 · Molecular Therapy — Methods & Clinical Development
2. Upstream insights for lentiviral vector production: cell platforms, culture parameters, and titer yields
   Pedram Abdollahpour, Alireza Shafizadeh, Ehsan Arefian · 2026 · Cytotechnology
3. Gene editing approaches of microsatellite disorders : shortening expanded repeats
   Lucie Poggi · 2020 · theses.fr (ABES)
4. Autotransduction and Pseudotyping as a Key Limitations in Lentiviral Vector Production
   Filip Walczak, Anna Szymkiewicz, Ilona Pacak, Artur Kowalik · 2026 · Biotechnology Journal
5. Challenges and opportunities in continuous bioprocessing of lentiviral vectors and adeno-associated viral vectors
   Alexandra Solis Olivares, Agnes Julia L. Aparte, Dale J. Stibbs, Pedro Silva Couto, Qasim A. Rafiq · 2026 · Biotechnology Advances
6. Quasi-perfusion method for scaling and optimisation of a suspension stable producer cell line for continuous manufacturing of lentiviral vectors at high cell density
   Ciara Lucas, Cristina Aleu Heredia, Yasuhiro Takeuchi, David Mainwaring, Martina Micheletti · 2026 · Biochemical Engineering Journal
7. From Platform Development to Scale-Up: Stable Producer Cell Line-Based Lentiviral Vector Manufacturing
   Ane Arrasate, Igone Bravo, Haizea Fernandez, Carolina Amagliani, Carlos Salgado, Maria Garcia, Carolina Guiance, Maite Azcarate, Tania Arias, Carlos Lopez-Robles et al. · 2026 · Pharmaceutics
8. A mechanistic model of lentiviral vector production identifies intracellular plasmid availability and vRNA-GagPol temporal asynchrony as key yield-limiting factors
   Daoyuan Na, Lei Cao, Naixiang Cui, Wen-Song Tan · 2026 · Biochemical Engineering Journal